Molecular Insight into the Therapeutic Promise of Targeting for Alzheimer's Disease.

Alzheimer's disease (AD) is a progressive neurodegenerative disease that causes chronic cognitive dysfunction. Most of the AD cases are late onset, and the apolipoprotein E () isoform is a key genetic risk factor. The gene has 3 key alleles in humans including , , and .